These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 7686468)

  • 1. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy.
    Peters DH; Sorkin EM
    Drugs; 1993 May; 45(5):760-87. PubMed ID: 7686468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of zonisamide as an anti-epileptic drug.
    Jain KK
    Expert Opin Pharmacother; 2000 Sep; 1(6):1245-60. PubMed ID: 11249491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research and development of zonisamide, a new type of antiepileptic drug].
    Shimizu M; Uno H; Ito T; Masuda Y; Kurokawa M
    Yakugaku Zasshi; 1996 Jul; 116(7):533-47. PubMed ID: 8831258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide: review of its use in epilepsy therapy.
    Zareba G
    Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonisamide: a review of its use in the management of partial seizures in epilepsy.
    Frampton JE; Scott LJ
    CNS Drugs; 2005; 19(4):347-67. PubMed ID: 15813651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
    Goa KL; Ross SR; Chrisp P
    Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy.
    Kwan SY; Chuang YC; Huang CW; Chen TC; Jou SB; Dash A
    CNS Neurosci Ther; 2015 Sep; 21(9):683-91. PubMed ID: 26205514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide in pediatric epilepsy: review of the Japanese experience.
    Glauser TA; Pellock JM
    J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to zonisamide.
    Baulac M
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and drug interactions with zonisamide.
    Sills G; Brodie M
    Epilepsia; 2007 Mar; 48(3):435-41. PubMed ID: 17319920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide: its pharmacology, efficacy and safety in clinical trials.
    Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L
    Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide: new drug. No advantage in refractory partial epilepsy.
    Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.
    Kothare SV; Kaleyias J
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):493-506. PubMed ID: 18433351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of Japanese experience-controlled and uncontrolled trials.
    Yagi K
    Seizure; 2004 Dec; 13 Suppl 1():S11-5; discussion S16. PubMed ID: 15511680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy.
    Wallander KM; Ohman I; Dahlin M
    Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.